Russell Investments Group, Ltd. Ocular Therapeutix, Inc Transaction History

Russell Investments Group, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$2.61 - $4.41 $45,367 - $76,654	-17,382 Reduced 56.17%	13,561 $38,000
Q3 2022 Nov 04, 2022	BUY	$4.09 - $6.5 $126,556 - $201,129	30,943 New	30,943 $128,000
Q1 2021 May 10, 2021	SELL	$15.82 - $22.11 $8,890 - $12,425	-562 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$7.91 - $22.95 $4,445 - $12,897	562 New	562 $11,000

148

123M

185K

507K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $526M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.